Project Details
Description
A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects
| Status | Active |
|---|---|
| Effective start/end date | 2/6/19 → 6/30/25 |
Funding
- ANSUN BIOPHARMA, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.